Patents by Inventor Maria Garcia

Maria Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9725483
    Abstract: Compounds of general formula (I): Ri—Wn—Xm-AAi-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2 (I) their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, preparation processes, cosmetic and/or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, pigmentation disorders and angiogenic skin disorders, and in processes of treatment and/or care of the skin and/or mucous membranes.
    Type: Grant
    Filed: April 16, 2013
    Date of Patent: August 8, 2017
    Assignee: LIPOTEC, S.A.
    Inventors: José María García Antón, Antonio Vicente Ferrer Montiel, Cristina Carreño Serraïma, Raquel Delgado González, Juan Cebrián Puche
  • Publication number: 20170217973
    Abstract: Novel compounds for use in cognition improvement It relates to certain compounds having a polycyclic structure and a —(C?O)NRaRb moiety, wherein the polycyclic structure comprises at least three ring systems, wherein one ring system is a polycyclic ring system comprising from 2 to 4 rings; at least one ring is an aromatic ring; and wherein the structure comprises at least 3 nitrogen atoms and 1 oxygen atom. It also relates to pharmaceutical compositions containing them, and to their use in medicine, in particular in the treatment and/or prevention of neurological disorders coursing with a cognition deficit or impairment, or neared-generative diseases.
    Type: Application
    Filed: August 3, 2015
    Publication date: August 3, 2017
    Inventors: María del Mar CUADRADO TEJEDOR, Ana Maria GARCÍA OSTA, Julen OYARZABAL SANTAMARINA, Maria Obdulia RABAL GRACIA, Juan Antonio SÁNCHEZ ARIAS, Ana UGARTE BAZTÁN
  • Patent number: 9682991
    Abstract: There is provided compounds of formula (I), wherein R1, R2, R3 and R4 have meanings given in the description (and which compounds are optionally substituted as indicated in the description), and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PIM family kinase, such as PIM-1, PIM-2 and/or PIM-3) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease. There is also provided combinations comprising the compounds of formula (I).
    Type: Grant
    Filed: December 31, 2010
    Date of Patent: June 20, 2017
    Assignee: FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III
    Inventors: Joaquín Pastor Fernández, Francisco Javier Ramos Lima, Ana Isabel Hernandez Higueras, Sonia Martínez González, Jose Ignacio Martín Hernando, Carl-Gustave Pierre Saluste, Esther Gonzalez Cantalapiedra, Carmen Blanco Aparicio, Antonio Rodríguez Hergueta, Ana Maria Garcia Collazo, Antonio Salgado Serrano, Beatriz Noya Marino
  • Patent number: 9651022
    Abstract: A method of manufacturing wind turbine blades of variable length with connection elements with the rotor hub. The method includes providing and using enlarged manufacturing molds having a common zone of a predetermined length and, at least, an adaptive zone arranged with the length needed for manufacturing the blades with a desired length, particularly the length required for optimizing the annual energy production (AEP) of a predetermined wind turbine model in a predetermined site.
    Type: Grant
    Filed: June 27, 2012
    Date of Patent: May 16, 2017
    Assignee: GAMESA INNOVATION & TECHNOLOGY, S.L.
    Inventors: Ion Arocena De La Rua, Eneko Sanz Pascual, Maria Garcia Fernandez Aviles, Raquel Aguilar Melendez
  • Patent number: 9605401
    Abstract: The present invention relates to a gravity-based foundation system for offshore wind turbine installation that comprises three floating concrete bases built with self-floating concrete caissons, equipped with valves for filling them with water and emptying the water out enabling their ballasting and anchoring at their final location; a metal structure which connects the floating concrete bases by means of a connecting element to the wind turbine tower, and a metal element which connects the floating concrete bases to the wind turbine, metal element on which a docking area is installed, a maintenance platform and access stairs, and it also relates to a method of installation of the gravity-based foundation system.
    Type: Grant
    Filed: May 28, 2013
    Date of Patent: March 28, 2017
    Assignee: Tecnica y Proyectos, S.A.
    Inventors: Javier Ivars Salom, Rafael Molina Sanchez, Jose Maria Garcia-Valdecasas Bernal, Miguel Angel Cabrerizo Morales
  • Publication number: 20170079334
    Abstract: A bra assembly includes a bra that has a pair of cups and a primary strap. The primary strap has a first end and a second end and the primary strap may be wrapped around an upper torso of a user having each of the cups being positioned on a chest of the user. A pair of secondary straps is provided and each of the secondary straps is coupled to the bra. Each of the secondary straps may be extended over an associated one of a pair of shoulders of the user. A pair of clips is provided and each of the clips is attached to an associated one of the secondary straps. Each of the clips removably engages an associated one of the cups thereby facilitating each of the secondary straps to be removed from the cups while the bra is being worn by the user.
    Type: Application
    Filed: September 18, 2015
    Publication date: March 23, 2017
    Inventor: Maria Garcia
  • Patent number: 9573956
    Abstract: It relates to certain compounds having a polycyclic structure and a hydroxamic acid moiety, wherein the polycyclic structure comprises at least three ring systems, wherein one ring system is a polycyclic ring system comprising from 2 to 4 rings; at least one ring is an aromatic ring; and wherein the structure comprises at least 3 nitrogen atoms and 1 oxygen atom. It also relates to a process for their preparation, as well as to pharmaceutical compositions containing them, and to their use in medicine, in particular in the treatment and/or prevention of neurological disorders coursing with a cognition deficit or impairment, or neurodegenerative diseases.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: February 21, 2017
    Assignee: FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA
    Inventors: María Del Mar Cuadrado Tejedor, Rafael Franco Fernández, Ana María García Osta, Julen Oyarzabal Santamarina, Maria Obdulia Rabal Gracia
  • Publication number: 20170020132
    Abstract: The present invention relates to the use of a fructooligosaccharide (FOS) comprising from 2 to 10 monosaccharide units, as an elicitor of the mechanisms of absorption of mineral elements from the soil, and of the defense mechanisms against pathogens. It also relates to a fertilizing and biostimulating composition containing these fructooligosaccharides, and to the use thereof in a method for treating crop plants.
    Type: Application
    Filed: April 8, 2015
    Publication date: January 26, 2017
    Inventors: Javier ERRO GARCES, Oscar URRATIA SAGARDIA, Maria GARNICA OCHOA, Diane LEMENAGER, Esther CASANOVA PORTILLO, Jose Maria GARCIA-MINA FREIRE, Jean-Claude YVIN
  • Publication number: 20170022119
    Abstract: The invention relates to a fertilizing product, for example a potash fertilizer, the release of which is controlled and delayed by a coating comprising a first layer based on a polysaccharide resin obtained from a vegetable oi, and a second layer based on a non-hydrated cement.
    Type: Application
    Filed: April 1, 2014
    Publication date: January 26, 2017
    Inventors: Yves ALIS, Anne-Francoise BLANDIN, Javier ERRO, Jose-Maria GARCIA-MINA, Vincent JACQUOT, Oscar URRUTIA, Jean-Claude YVIN, Andre ZANBINI
  • Publication number: 20160340320
    Abstract: The present invention relates to a family of S-substituted quinazoline derivatives that inhibitors of the enzyme phosphodiesterase 7 (PDE7), useful for the treatment or prevention of diseases mediated by said enzyme, especially inflammatory, neurodegenerative, neurological, psychiatric and/or autoimmune diseases.
    Type: Application
    Filed: May 17, 2016
    Publication date: November 24, 2016
    Inventors: Ana Martinez Gil, Carmen Belen Gil Ayuso-Gontan, Daniel Ignacio Perez Fernandez, Ana Maria Garcia Fernandez
  • Patent number: 9441157
    Abstract: This disclosure refers to the fabrication of an active oxygen-absorbing compound composed of a sodium erythorbate and a non-organic salt of a transition metal encapsulated through the sol-gel method in a silica matrix. This compound can be part of the package's structure for oxidation-sensitive products or contained in the surrounding atmosphere to decrease the oxygen concentration. This application describes the method for the fabrication of the oxygen-absorber, as well as its encapsulation and incorporation in polymeric matrixes.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: September 13, 2016
    Assignee: UNIVERSIDAD DE LOS ANDES
    Inventors: Jorge Alberto Medina Perilla, Angela Maria Garcia Mora, Andrea Marcela Arias Herrera, Ronald Vicente Joven Pineda
  • Publication number: 20160235729
    Abstract: The present invention provides 5-(4-(2-(5-(1-hydroxyethyl)pyridine-2-yl)ethoxy) benzyl)thiazolidine-2,4-dione and novel stereoisomers of said compound for use in the treatment of central nervous system (NS) disorders.
    Type: Application
    Filed: May 5, 2016
    Publication date: August 18, 2016
    Applicant: MINORYX THERAPEUTICS S.L.
    Inventors: Ana Maria Garcia Collazo, David John Augustus Eckland, Maria Pilar Pizcueta Lalanza, Marc Martinell Pedemonte
  • Patent number: 9393187
    Abstract: Compounds of general formula (I): R1-Wn-Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp-Zq-R2 (I) their stereoisomers, mixtures thereof, their cosmetically or pharmaceutically acceptable salts and/or its functionally equivalent variants, preparation processes, cosmetic or pharmaceutical compositions which contain them and their use in medicine, particularly in the treatment and/or prevention of pain, inflammation, itching, neurological, compulsive and/or neuropsychiatric diseases and/or disorders and in processes of treatment and/or care of the skin, hair and/or mucous membranes mediated by neuronal exocytosis.
    Type: Grant
    Filed: April 12, 2013
    Date of Patent: July 19, 2016
    Assignee: Lubrizol Advanced Materials, Inc.
    Inventors: Antonio Vicente Ferrer Montiel, Gregorio Fernández Ballester, José María García Antón, Cristina Carreño Serraïma, Núria Almiñana Doménech, Raquel Delgado González
  • Publication number: 20160173387
    Abstract: A system for improving network data communications performance between end-user devices and content origin servers. A plurality of accelerators are distributed across a network and communicate with end-user devices and content origin servers. Software development kits installed on end-user devices monitor control channel data traffic between the end-user devices and accelerators. Various data traffic efficiency approaches are implemented by the software development kits on the end-user devices and the plurality of accelerators resulting in improved data communications links between the end-user devices and the content origin servers.
    Type: Application
    Filed: December 15, 2015
    Publication date: June 16, 2016
    Inventors: Kartikeya Chandrayana, Satish Raghunath, Radha Krishna Pagadala, Shauli Gal, Maria Garcia Cerdeno, Russell Larsen
  • Publication number: 20160168132
    Abstract: The present invention refers to compounds of formula (I): as well as to a method for their preparation, pharmaceutical compositions comprising the same, and use thereof for the treatment and/or prevention of conditions associated with the alteration of the activity of ?-galactosidase, specially galactosidase beta-1 or GLB1, including GM1 gangliosidoses and Morquio syndrome, type B.
    Type: Application
    Filed: July 30, 2014
    Publication date: June 16, 2016
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Xavier BARRIL ALONSO, Ana Maria GARCÍA COLLAZO, Juan AYMAMI BOFARULL, Marc REVÉS VILAPLANA, Rodolfo LAVILLA GRIFOLS, Marc MARTINELL PEDEMONTE
  • Patent number: 9337521
    Abstract: A circuit component is described herein. The circuit component includes a first signal line to propagate in a first direction and a second signal line to propagate a second direction. The circuit component includes a region to introduce crosstalk within the region that reduces another crosstalk generated at a location remote from the region based on a change in propagation direction of the first signal line and second signal line.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: May 10, 2016
    Assignee: Intel Corporation
    Inventors: Raul Enriquez Shibayama, Maria Garcia Garcia de Leon, Kai Xiao, Beom-Taek Lee, Carlos Lizalde Moreno
  • Patent number: 9333152
    Abstract: The present invention refers to a peptide of general formula (I) R1-Wn-Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp-Zq-R2, cosmetic compositions which comprises said peptide, method of preparation of said peptides and its use in the treatment and/or prevention of itching, inflammation, pain, diseases and/or disorders of the respiratory airways.
    Type: Grant
    Filed: October 31, 2012
    Date of Patent: May 10, 2016
    Assignee: Lipotec, S.A.
    Inventors: Antonio Vicente Ferrer Montiel, José María García Antón, Raquel Delgado González
  • Publication number: 20160120549
    Abstract: Described here are devices for closing one or more tissues, and handles for controlling these devices. Generally, the devices described here comprise a snare loop assembly, wherein the snare loop assembly comprises a snare and a suture loop, and a handle for controlling the snare loop assembly. In some variations the snare loop assembly may comprise a retention member that may releasably connect the suture loop to the snare. In other variations the devices comprise one or more force-reducing suture locks to help prevent the suture loop from inadvertently disengaging from the snare loop assembly. In still other variations, the excess-suture management features. The handles described here may be configured to remove excess suture from a suture loop, and may also be configured to release the suture loop from the snare loop assembly.
    Type: Application
    Filed: October 30, 2015
    Publication date: May 5, 2016
    Inventors: Gregory W. FUNG, Russell A. SEIBER, Eduardo SAGER, JR., Gary H. MILLER, Maria GARCIA, Ryan Douglas HELMUTH, Arnold M. ESCANO, Douglas Todd ELLISON, William E. COHN
  • Patent number: 9266921
    Abstract: Peptides of general formula (I): R1—Wn—Xm-AA1-AA2-AA3-AA4-AA5-AA6-Yp—Zq—R2 their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, a preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases which improve or are prevented by PGC-1? modulation.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: February 23, 2016
    Assignee: Lipotec, S.A.
    Inventors: José María García Antón, Nuria Almiñana Domenech, Antonio Vicente Ferrer Montiel
  • Publication number: 20160002246
    Abstract: It relates to certain compounds having a polycyclic structure and a hydroxamic acid moiety, wherein the polycyclic structure comprises at least three ring systems, wherein one ring system is a polycyclic ring system comprising from 2 to 4 rings; at least one ring is an aromatic ring; and wherein the structure comprises at least 3 nitrogen atoms and 1 oxygen atom. It also relates to a process for their preparation, as well as to pharmaceutical compositions containing them, and to their use in medicine, in particular in the treatment and/or prevention of neurological disorders coursing with a cognition deficit or impairment, or neurodegenerative diseases.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 7, 2016
    Inventors: Maria Del Mar CUADRADO TEJEDOR, Rafael FRANCO FERNÁNDEZ, Ana Maria GARCÍA OSTA, Julen OYARZABAL SANTAMARINA, Maria Obdulia RABAL GRACIA